Cryoport expands integricell™ cryopreservation services solution with opening of new center of excellence in europe

Facility dedicated to cryopreservation of leukapheresis starting materials to support clinical and commercial cell-based therapy programs nashville, tenn. , nov. 12, 2024 /prnewswire/ -- cryoport, inc. (nasdaq: cyrx) ("cryoport" or the "company"), a global leader in supply chain solutions for the life sciences industry, today announced the opening of its newest integricell™ facility in villers-le-bouillet, liege, belgium.
CYRX Ratings Summary
CYRX Quant Ranking